Ligand Pharmaceuticals
LGND | NASDAQ
$292.19
+$2.12 (+0.73%)
Sep 22, 2026, 1:01 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 1.36B | 115.08M | 174.93M | 139.38M | 67.67M | 47.99M | 72.31M | 63.62M | 18.14M | 50.09M | 22.95M | 19.28M | 28.45M | 88.73M | 45.01M | 4.12M | 5.28M | 14.99M | 19.52M | 23.43M | 21.86M | 31.85M |
Short-Term Investments | 351.06M | 664.33M | 558.59M | 525.15M | 187.63M | 160.91M | 183.86M | 156.02M | 208.79M | 260.5M | 147.36M | 171.23M | 190.6M | 193.94M | 166.86M | 117.29M | 142.66M | 189.01M | 321.59M | 299.78M | 279.97M | 307.35M |
Long-Term Investments | 42.39M | 132.81M | 183.58M | 42M | 204.46M | 199.23M | 195.93M | 212.4M | 93.66M | 112.68M | 111.61M | 47.08M | n/a | n/a | 3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | -145.97M | 2.71M | 1.79M | 325.18M | 27.07M | 25.92M | 17.51M | 27.65M | 46.43M | 11.23M | 9.92M | 8.43M | 4.5M | 16.38M | 1.74M | 39.7M | 37.27M | 6.44M | 272.03M | 3.1M | 2.83M | 3.05M |
Receivables | 67.01M | 54.8M | 61.05M | 58.1M | 42.12M | 42.83M | 42.45M | 42.13M | 37.48M | 28.44M | 39.31M | 36M | 27.99M | 29.19M | 35.04M | 65.95M | 63.27M | 41.8M | 91.65M | 70.71M | 62.85M | 55.58M |
Inventory | n/a | 13.27M | 9.13M | 11.9M | 12.89M | 11.81M | 14.11M | 13.44M | 14.47M | 21.34M | 23.97M | 25.39M | 26.91M | 14.01M | 13.29M | 22.33M | 24.77M | 25.61M | 27.33M | 33M | 39.95M | 36.93M |
Other Current Assets | n/a | 17.95M | 28.58M | 19.4M | 40.04M | 42.97M | 16.9M | 30.87M | 27.26M | 7.31M | 2.66M | 2.1M | 2.77M | 2.33M | 2.27M | 10.75M | 7.8M | 4.66M | 4.67M | 5.16M | 6.27M | 5.71M |
Total Current Assets | 1.42B | 865.42M | 832.27M | 753.92M | 352.95M | 309.32M | 331.56M | 309.39M | 312.26M | 368.91M | 237.43M | 253.99M | 276.71M | 328.2M | 263.6M | 220.43M | 243.78M | 276.07M | 464.75M | 432.08M | 410.9M | 437.43M |
Property-Plant & Equipment | n/a | 10.28M | 10.79M | 11.08M | 11.62M | 10.49M | 24.81M | 25.19M | 25.46M | 24.38M | 25.06M | 25.98M | 26.54M | 15.61M | 27.49M | 46.55M | 39.74M | 55.99M | 32.6M | 48.45M | 41.51M | 42.46M |
Goodwill & Intangibles | 310.79M | 512.42M | 523.86M | 335.08M | 351.67M | 359.93M | 371.9M | 380.16M | 388.41M | 396.67M | 402.98M | 425.22M | 441.83M | 450.02M | 458.31M | 708.42M | 719.84M | 731.03M | 492.47M | 763.3M | 773.16M | 784.75M |
Total Long-Term Assets | 207.21M | 666.69M | 728.37M | 722.85M | 595.66M | 596.12M | 610.22M | 645.48M | 554.15M | 544.96M | 549.79M | 515.23M | 481.39M | 482.88M | 499.07M | 830.17M | 832.5M | 829.12M | 832.84M | 841.57M | 845.38M | 857.69M |
Total Assets | 2.19B | 1.53B | 1.56B | 1.48B | 948.6M | 905.44M | 941.77M | 954.87M | 866.41M | 913.87M | 787.22M | 769.23M | 758.11M | 811.08M | 762.67M | 1.05B | 1.08B | 1.11B | 1.3B | 1.27B | 1.26B | 1.3B |
Account Payables | n/a | 5.26M | 3.24M | 27.76M | 8.58M | 5.37M | 5.23M | 4.69M | 1.79M | 1.89M | 2.43M | 2.48M | 9.58M | 6.14M | 5.31M | 15.89M | 19.15M | 6.97M | 8.4M | 7.23M | 17.27M | 9.47M |
Deferred Revenue | n/a | 621K | 621K | 135K | 732K | 722K | 1.9M | 1.77M | 1.82M | 1.85M | 1.84M | 621K | 621K | 257K | 976K | 9.55M | 10.58M | 10.5M | 654K | 12.01M | 17.15M | 25.11M |
Short-Term Debt | n/a | n/a | n/a | 1.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 76.79M | 76.7M | 76.6M | 114.97M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 46.74M | 4.13M | 6.81M | -821K | 39.67M | 28.88M | -3.2M | 3.96M | 2.83M | 2.03M | 4.94M | 3.81M | 2.79M | 13.32M | 6.26M | 14.88M | 12.14M | 5.14M | 22.57M | 7.26M | 9.44M | 45.54M |
Total Current Liabilities | 46.74M | 40.67M | 37.45M | 30.54M | 64.73M | 58.68M | 37.11M | 24.77M | 18.57M | 17.82M | 16.78M | 15.73M | 29.39M | 98.93M | 98.81M | 135.24M | 167.85M | 42.58M | 41.67M | 36.3M | 52.5M | 95.81M |
Long-Term Debt | 1.13B | 446.9M | 446.19M | 445.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 176.54M | 320.72M | 316.89M | 315.32M | 352.31M |
Other Long-Term Liabilities | 19.6M | 20.61M | 2.97M | 23.48M | 18.47M | 18.27M | 35.88M | 33.74M | 18.59M | 16.97M | 17M | 47.19M | 25.17M | 24.64M | 25.38M | 28.8M | 28.89M | 36.64M | 80.94M | 33.91M | 37.13M | 38.27M |
Total Long-Term Liabilities | 1.17B | 494.12M | 505.98M | 496.06M | 55.34M | 51.22M | 74.22M | 88.92M | 72.64M | 89.53M | 69.52M | 85.6M | 63.83M | 65.83M | 66.37M | 99.07M | 106.07M | 269.41M | 434.77M | 425.29M | 417.27M | 453.48M |
Total Liabilities | 1.22B | 534.78M | 543.43M | 526.6M | 120.08M | 109.9M | 111.34M | 113.69M | 91.21M | 107.35M | 86.3M | 101.33M | 93.21M | 164.76M | 165.18M | 234.31M | 273.92M | 311.99M | 476.43M | 461.59M | 469.77M | 549.28M |
Total Debt | 1.13B | 451.98M | 451.49M | 451M | 5.74M | 4.45M | 7.11M | 7.36M | 7.58M | 6.19M | 6.17M | 6.33M | 11.67M | 88.68M | 87.75M | 113.89M | 144.61M | 195.2M | 324.39M | 330.58M | 322.41M | 366M |
Book Value | 967.52M | 997.32M | 1.02B | 950.17M | 828.53M | 795.53M | 830.44M | 841.18M | 775.2M | 806.52M | 700.91M | 667.9M | 664.89M | 646.32M | 597.49M | 816.3M | 802.37M | 793.19M | 821.16M | 812.07M | 786.52M | 745.84M |
Book Value Per Share | 44.31 | 50.16 | 48.12 | 47.11 | 41.58 | 41.45 | 43.77 | 45.67 | 43 | 44.51 | 39.65 | 38.43 | 37.50 | 35.96 | 35.38 | 47.65 | 47.57 | 47.15 | 49.07 | 47.37 | 45.80 | 43.24 |
Common Stock | 20K | 20K | 20K | 20K | 20K | 20K | 20K | 19K | 19K | 18K | 18K | 18K | 17K | 17K | 17K | 17K | 17K | 17K | 17K | 17K | 17K | 17K |
Retained Earnings | 583.25M | 594.74M | 608.09M | 578.22M | 461.38M | 456.53M | 498.98M | 530.07M | 537.24M | 589.16M | 503.02M | 484.83M | 495.1M | 492.81M | 450.86M | 468.35M | 467.94M | 468.84M | 449.09M | 454.51M | 440.78M | 410.06M |
Comprehensive Income | 4.48M | 5.39M | 8.46M | 9.32M | 8.49M | -1.56M | -5.94M | 1.75M | -935K | -910K | -817K | -944K | -967K | -935K | -984K | -1.06M | -1.07M | -1.03M | -917K | -875K | -861K | -856K |
Shareholders Equity | 967.52M | 997.32M | 1.02B | 950.17M | 828.53M | 795.53M | 830.44M | 841.18M | 775.2M | 806.52M | 700.91M | 667.9M | 664.89M | 646.32M | 597.49M | 816.3M | 802.37M | 793.19M | 821.16M | 812.07M | 786.52M | 745.84M |
Total Investments | 393.45M | 797.14M | 742.18M | 567.15M | 392.09M | 360.14M | 379.79M | 368.43M | 302.45M | 373.18M | 258.97M | 218.31M | 190.6M | 193.94M | 169.86M | 117.29M | 142.66M | 189.01M | 321.59M | 299.78M | 279.97M | 307.35M |
Add to Watchlist
Select watchlists to add or remove LGND